Kindstar Globalgene Technology, Inc. disclosed a small-scale share buyback conducted on 10 June 2026 under its Hong Kong listing obligations. The company repurchased 20,000 ordinary shares on the Stock Exchange of Hong Kong at HKD 1.02 per share, for a total consideration of HKD 20,400.

Following the transaction, Kindstar’s outstanding share count (excluding treasury shares) declined by 0.00193 % to 1,034.19 million shares. Treasury shares increased to 7.14 million, while the total issued share capital remained unchanged at 1.04 billion shares.

The purchase forms part of the repurchase mandate approved on 5 June 2026, which authorises the company to buy back up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 77,500 shares, representing 0.00749 % of the shares outstanding on the mandate date. All shares acquired to date are being held as treasury stock.

In accordance with Hong Kong Listing Rules, Kindstar is subject to a moratorium on issuing new shares or disposing of treasury shares until 10 July 2026.